ARCHIVES

NCCS Appointment Marks Transition To New Structure.

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | March 17, 2000

Download PDF Visit The Full Archive

Related Articles

Xgeva Delays Metastases To Bone, Amgen Files To Expand Indication

November 25, 2011

ODACSupports Temodal For Treatment of Astrocytoma

January 22, 1999

NCI Dispute GAO Charge That Cancer Control Contracts Were Mishandled

August 15, 1980

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

Most Comprehensive Centers Score High; Few May Be In Trouble; Directors Back Program

May 19, 1978

Letter: Biostatistics Directors Invited To Share Concerns

June 7, 1996